ICCPSCI 2016 - 2016 International Conference on Clinical Medicine and Pharmacology
View: 637
Website http://www.iccpsci.org/ |
Edit Freely
Category Preclinical Medicine;Clinical Medicine
Deadline: October 15, 2016 | Date: December 19, 2016-December 20, 2016
Venue/Country: shanghai,china, China
Updated: 2016-06-10 19:54:04 (GMT+9)
Call For Papers - CFP
Topics of interest include, but are not limited to: A. Preclinical Medicine1. Simulation-based medical education2. Developmental Neurobiology3. Essential clinical anatomy4. Study on immune signaling5. Tumor immunology 6. Etiology and pathology of tumor7. Tumor biomarkers and tumor metastasis8. Study on etiology, epidemiology, pathogenisis of emerging infectious diseases.9. Parasitic infection and immunity.10. Gene Expression and Regulation, Genomics 11. Protein structure and function, Proteomics12. Cell signaling and regulation13. Biotechnology and bioindustryB. Clinical Medicine1. Basic and Clinical Studies on Cardiovascular and cerebrovascular diseases2. Basic and clinical reaserch of digestive system disease3. State-of- the-art technology in surgery4. Clinical and fundamental study on dermatovenereology5. Experimental and clinical study in obstetrics and gynaecology 6. Advances in electrical and electrnics technology in medical imaging7. Clinical nursing8. Nursing education9. Diagnostic technology and method for patho-biology10. Immunological indicator and technology of disease11. Diagnostic indicator and technology of hematopathy 12. Medical biochemistry inspection and diagnosis13. Molecular diagnosis of disease
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.